Asia Pacific Remain Fastest Expanding Market for Automated Immunoassay Analyzer

Posted by Arslan on January 23rd, 2018

Over the years, immunoassays have been utilized in clinical chemistry, and are currently being used widely in quality control and research & development in food & beverage and pharmaceutical & biotechnology industries, on the back of their rapid test time and specificity. A new report has been added to the vast repository of Market Research Report Search Engine (MRRSE), titled “Automated Immunoassay Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025”. According to the report, shortfall of skilled workforce and increasing test volume have led manufacturers to emphasize on technological advancements, which in turn has resulted into the development of the automated immunoassay analyzers.

The global market for automated immunoassay analyzers are is projected to exhibit a modest expansion over the forecast period, 2017 to 2025. Over US$ 3.5 Bn worth of automated immunoassay analyzers are estimated to be sold worldwide by 2025-end.

Growing Disease Epidemics & Laboratory Consolidation Prompting Laboratory Automation & Integration

Over the past few years, there has been a rapid rise in incidences of disease epidemics and chronic ailments such as hepatitis infection, HIV, and Zica, which in turn has proliferated hospital admissions and clinical tests. Besides, there has been a surge in consolidation in preventive healthcare and laboratories. These factors have further prompted laboratory automation and integration, thereby creating lucrative opportunities for automated immunoassay analyzer adoption. Demand for these analyzers is also being driven by rapid rise in international standardization and growing requirement for efficient result comparability.

However, reeling under cost constraints, small diagnostic laboratories will continue to face challenges regarding automated immunoassay analyzers adoption. Meanwhile, laboratories in developed markets are expected to face challenges on the back of declining reimbursements. In addition, implementation of stringent regulations with regard to product approvals, and the incessant requirement for working under escalating cost pressures are likely to impact the business flow of laboratories, thereby hindering automated immunoassay analyzers market’s expansion adversely. In a bid to overcome these obstacles, majority of diagnostic laboratories are concentrating on high volume testing for boosting profitability per test.

Read the Complete Report with TOC @ https://www.mrrse.com/automated-immunoassay-analyzers-market

CLIA Analyzers Technology to Account for Largest Market Revenues Share during 2017-2025

According to the report, chemiluminescence immunoassay (CLIA) analyzers will continue to account for the largest revenue share of the market during 2017 to 2025, on the basis of technology. In addition, sales of CLIA analyzers are projected to reflect a relatively higher expansion compared to other technology segments in the market through 2025.

The report estimates outright sale to remain the leading sales model in the global automated immunoassay analyzers market, based on sales expansion. This can be highly attributed to growing focus of key players to capitalize on outright sale for enhancing their cash flows and avoiding recurring cost on maintenance and services. Based on end-users, diagnostic laboratories will continue to dominate the global automated immunoassay analyzers market during the forecast period.

North America to Remain Dominant in the Market

In terms of revenues, North America will continue to be dominant in the global automated immunoassay analyzers market. This is mainly because the region is home to large number of global leaders in the market. Besides, high technology adoption, and growing demand for immunoassay analyzers that are clinically efficient will further drive the market growth in North America. However, the market in Asia Pacific is projected to register the fastest expansion through 2025.

Key companies profiled by the report that are actively contributing to the market expansion include Siemens Healthineers, bioMérieux SA, Beckman Coulter, Inc., Radiometer APS, F. Hoffmann-La Roche Ltd., SNIBE Diagnostics, Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Inc., Ortho Clinical Diagnostics, Randox Laboratories, DiaSorin S.p.A., and Sysmex Corporation.